Phase I trial of the angiogenesis inhibitor TNP-470 for progressive androgen-independent prostate cancer
- Christopher J. Logothetis
- , Kenneth K. Wu
- , Laury D. Finn
- , Danai Daliani
- , William Figg
- , Habib Ghaddar
- , Jordan U. Gutterman
Research output: Contribution to journal › Article › peer-review
155
Scopus
citations